Drug Type Small molecule drug |
Synonyms VGVX, API 1177, VG 1177 + [1] |
Target |
Mechanism CD74 inhibitors(HLA-DR antigens-associated invariant chain inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries | Preclinical | CA | - | |
Epilepsy | Preclinical | US | - | |
Epilepsy | Preclinical | US | - | |
HIV Infections | Preclinical | US | - | |
HIV Infections | Preclinical | CA | - | |
Pre-Eclampsia | Preclinical | CA | - | |
Inflammatory Bowel Diseases | Discovery | US | - |